Cargando…
Geographic heterogeneity in the outcomes of patients receiving immune checkpoint inhibitors for advanced solid tumors: a meta-analysis
BACKGROUND: Little is known about the effect of geographic location on efficacy of immune checkpoint inhibitors (ICI). We performed a systematic review and meta-analysis to assess the heterogeneity of ICI efficacy between different geographic locations. METHODS: We searched PubMed, EMBASE, and the C...
Autores principales: | Li, Manyu, Yao, Jiannan, Zhang, Huiyun, Ge, Yang, An, Guangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797443/ https://www.ncbi.nlm.nih.gov/pubmed/35116262 http://dx.doi.org/10.21037/tcr-20-1800 |
Ejemplares similares
-
Balancing the Risk-Benefit Ratio of Immune Checkpoint Inhibitor and Anti-VEGF Combination Therapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Tao, Li, et al.
Publicado: (2021) -
Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials
por: Ge, Yang, et al.
Publicado: (2021) -
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
por: Gilbert, Danielle, et al.
Publicado: (2023) -
Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study
por: Long, Yaping, et al.
Publicado: (2023) -
Corrigendum to “Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients” Heliyon 9(6), (May 25, 2023)()
por: Yao, Jiannan, et al.
Publicado: (2023)